Federated Hermes’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.99M | Sell |
39,928
-123
| -0.3% | -$7.9K | ﹤0.01% | 942 |
|
|
2026
Q1 | $2.26M | Buy |
40,051
+1,154
| +3% | +$75.2K | ﹤0.01% | 950 |
|
|
2025
Q4 | $3.12M | Sell |
38,897
-7,207
| -16% | -$484K | 0.01% | 873 |
|
|
2025
Q3 | $2.25M | Buy |
46,104
+43,042
| +1,406% | +$2.66M | ﹤0.01% | 905 |
|
|
2025
Q2 | $228K | Buy |
3,062
+72
| +2% | +$4.77K | ﹤0.01% | 1468 |
|
|
2025
Q1 | $190K | Sell |
2,990
-564
| -16% | -$38.4K | ﹤0.01% | 1493 |
|
|
2024
Q4 | $277K | Sell |
3,554
-436
| -11% | -$35K | ﹤0.01% | 1433 |
|
|
2024
Q3 | $321K | Sell |
3,990
-29,358
| -88% | -$2.37M | ﹤0.01% | 1408 |
|
|
2024
Q2 | $2.76M | Sell |
33,348
-2,559
| -7% | -$225K | 0.01% | 850 |
|
|
2024
Q1 | $3.06M | Sell |
35,907
-3,185
| -8% | -$250K | 0.01% | 832 |
|
|
2023
Q4 | $3.34M | Sell |
39,092
-1,887
| -5% | -$163K | 0.01% | 817 |
|
|
2023
Q3 | $3.67M | Sell |
40,979
-896
| -2% | -$80K | 0.01% | 780 |
|
|
2023
Q2 | $3.57M | Buy |
41,875
+34,389
| +459% | +$2.91M | 0.01% | 786 |
|
|
2023
Q1 | $619K | Sell |
7,486
-364
| -5% | -$29.5K | ﹤0.01% | 1340 |
|
|
2022
Q4 | $617K | Sell |
7,850
-1,614
| -17% | -$130K | ﹤0.01% | 1294 |
|
|
2022
Q3 | $700K | Sell |
9,464
-1,827
| -16% | -$131K | ﹤0.01% | 1236 |
|
|
2022
Q2 | $736K | Sell |
11,291
-451,295
| -98% | -$26.7M | ﹤0.01% | 1257 |
|
|
2022
Q1 | $29.2M | Buy |
462,586
+320,184
| +225% | +$17.4M | 0.07% | 353 |
|
|
2021
Q4 | $7.55M | Buy |
142,402
+132,391
| +1,322% | +$8.07M | 0.01% | 728 |
|
|
2021
Q3 | $707K | Buy |
10,011
+3,879
| +63% | +$245K | ﹤0.01% | 1400 |
|
|
2021
Q2 | $409K | Sell |
6,132
-3,959
| -39% | -$280K | ﹤0.01% | 1554 |
|
|
2021
Q1 | $1.12M | Sell |
10,091
-383
| -4% | -$47.4K | ﹤0.01% | 1326 |
|
|
2020
Q4 | $1.24M | Sell |
10,474
-44,410
| -81% | -$4.78M | ﹤0.01% | 1248 |
|
|
2020
Q3 | $4.79M | Sell |
54,884
-21,670
| -28% | -$1.89M | 0.01% | 741 |
|
|
2020
Q2 | $6.86M | Buy |
76,554
+60,888
| +389% | +$6.15M | 0.02% | 630 |
|
|
2020
Q1 | $1.56M | Sell |
15,666
-80,169
| -84% | -$8.69M | ﹤0.01% | 969 |
|
|
2019
Q4 | $11M | Buy |
95,835
+9,820
| +11% | +$1.19M | 0.02% | 572 |
|
|
2019
Q3 | $10.8M | Buy |
86,015
+69,200
| +412% | +$8.78M | 0.03% | 548 |
|
|
2019
Q2 | $2.02M | Sell |
16,815
-5,658
| -25% | -$557K | ﹤0.01% | 1051 |
|
|
2019
Q1 | $1.97M | Sell |
22,473
-105,219
| -82% | -$9.57M | ﹤0.01% | 1055 |
|
|
2018
Q4 | $12.8M | Sell |
127,692
-37,042
| -22% | -$3.89M | 0.03% | 416 |
|
|
2018
Q3 | $18.9M | Sell |
164,734
-12,085
| -7% | -$1.25M | 0.04% | 371 |
|
|
2018
Q2 | $15.9M | Buy |
176,819
+31,551
| +22% | +$2.66M | 0.05% | 316 |
|
|
2018
Q1 | $10.6M | Buy |
145,268
+144,102
| +12,359% | +$9.89M | 0.03% | 403 |
|
|
2017
Q4 | $68K | Sell |
1,166
-31
| -3% | -$1.63K | ﹤0.01% | 1634 |
|
|
2017
Q3 | $54K | Sell |
1,197
-77
| -6% | -$3.2K | ﹤0.01% | 1636 |
|
|
2017
Q2 | $50K | Buy |
1,274
+16
| +1% | +$657 | ﹤0.01% | 1660 |
|
|
2017
Q1 | $51K | Sell |
1,258
-182
| -13% | -$7.11K | ﹤0.01% | 1621 |
|
|
2016
Q4 | $58K | Sell |
1,440
-151
| -9% | -$5.69K | ﹤0.01% | 1639 |
|
|
2016
Q3 | $58K | Sell |
1,591
-295
| -16% | -$10.1K | ﹤0.01% | 1616 |
|
|
2016
Q2 | $55K | Sell |
1,886
-214
| -10% | -$6.47K | ﹤0.01% | 1650 |
|
|
2016
Q1 | $73K | Hold |
2,100
| – | – | ﹤0.01% | 1606 |
|
|
2015
Q4 | $68K | Buy |
+2,100
| New | +$68.1K | ﹤0.01% | 1631 |
|
|
2015
Q1 | – | Sell |
-173
| Closed | -$6K | – | 2027 |
|
|
2014
Q4 | $6K | Sell |
173
-12
| -6% | -$440 | ﹤0.01% | 1806 |
|
|
2014
Q3 | $6K | Sell |
185
-1,572
| -89% | -$56.1K | ﹤0.01% | 1810 |
|
|
2014
Q2 | $62K | Sell |
1,757
-864
| -33% | -$28.9K | ﹤0.01% | 1620 |
|
|
2014
Q1 | $85K | Buy |
2,621
+2,124
| +427% | +$81.2K | ﹤0.01% | 1605 |
|
|
2013
Q4 | $21K | Buy |
+497
| New | +$20.5K | ﹤0.01% | 1689 |
|
Other funds holding HAE
AI
Federated Hermes's HAE Position: Q2 2026 in Review
Federated Hermes reduced its Haemonetics (HAE) stake by 0.31% in Q2 2026, selling an estimated $7.9K and leaving 39,928 shares worth $2.99M. The position accounts for ﹤0.01% of the portfolio, ranked #942.
Federated Hermes first reported a position in HAE in Q4 2013 and has held it in 48 quarters since. The position peaked at $29.2M in Q1 2022. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- Federated Hermes held 39,928 shares of Haemonetics worth $2.99M as of Q2 2026.
- Federated Hermes sold 123 Haemonetics shares in Q2 2026, an estimated $7.9K.
- Haemonetics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #942 holding.
- Federated Hermes first reported a position in Haemonetics in Q4 2013 and has held it in 48 quarters since.
- Federated Hermes's Haemonetics position peaked at $29.2M in Q1 2022.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.